News
Instead, McDowell snagged an invite, through his friend Donald Trump Jr., to a falconry trip Kennedy hosted. On a sunny day ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.
Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...
6h
Health and Me on MSNNovo Nordisk Launches Weight Loss Drug Wegovy In ThailandWegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
12h
Stocktwits on MSNNovo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast AsiaNovo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.
Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results